BiVictriX Therapeutics (BVX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 11.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 15.90
  • 52 Week Low: 10.50
  • Currency: UK Pounds
  • Shares Issued: 82.53m
  • Volume: 188,757
  • Market Cap: £9.49m

BVX Overview

BVX has identified a unique, cancer-restricted antigen fingerprint, absent from healthy cells, which can be exploited to produce cancer selective therapeutics. The Bi-Cygni® technology has been developed to exploit this concept and expedite the development of bispecific therapeutics with an improved therapeutic index. Based on BVX's work to date, these ADCs demonstrate superior potency and tumour selectivity compared to conventional ADCs. The main country of operation is in the UK.

1 Day Chart (18-04-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 2.4  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

BVX Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (0.51) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (2.53) (6.02)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (2.97) (3.78)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

BVX Company Announcements

Orphan Drug Designation & FDA INTERACT Meeting 17-Apr-2024 07:00 RNS
Grant of Options – PDMR/Direc... 28-Mar-2024 07:00 RNS
Holding(s) in Company 04-Jan-2024 12:30 RNS

BVX ShareCast News

BiVictriX gets patent for its lead asset in Japan 15-Nov-2023 ShareCast
BiVictriX posts promising preclinical data on le... 12-Oct-2023 ShareCast
BiVictriX appoints Adrian Howd as its new financ... 03-Oct-2023 ShareCast

Latest BVX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

BVX Market Data

Currency UK Pounds
Share Price 11.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 15.90
52 Week Low 10.50
Volume 188,757
Shares Issued 82.53m
Market Cap £9.49m

BVX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average
62.26% below the sector average62.26% below the sector average62.26% below the sector average62.26% below the sector average62.26% below the sector average
Price Trend
55.3% below the market average55.3% below the market average55.3% below the market average55.3% below the market average55.3% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income Not Available
Growth Not Available

BVX Dividends

No dividends found

Trades for 18-Apr-2024

Time Volume / Share Price
12:12 91,964 @ 11.03p
12:12 91,963 @ 11.00p
11:43 4,830 @ 11.00p

BVX Key Personnel

CEO Tiffany Jane Thorn

Top of Page